4-(2-[2-(2(R)-Methylpyrrolidin-1-yl)ethyl]benzofuran-5-yl)benzonitrile and Related 2-Aminoethylbenzofuran H3 Receptor Antagonists Potently Enhance Cognition and Attention
Authors:
- 13 December 2004
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 48 (1) , 38-55
Abstract
H3 receptor antagonists based on a 2-aminoethylbenzofuran skeleton have been discovered, which are potent in vitro at human and rat H3 receptors, with Ki values of 0.1−5.8 nM. Analogues were discovered with potent (0.01−1 mg/kg) cognition and attention enhancing properties in animal models. One compound in particular, 4-(2-[2-(2(R)-methylpyrrolidin-1-yl)ethyl]benzofuran-5-yl)benzonitrile (ABT-239), combined potent and selective H3 receptor antagonism and excellent pharmacokinetic and metabolic properties across species, with full efficacy in two behavioral models: a five-trial inhibitory avoidance acquisition model in rat pups at 0.1 mg/kg and a social recognition memory model in adult rats at 0.01 mg/kg. Furthermore, this compound did not stimulate locomotor activity and showed high selectivity for the induction of behavioral efficacy versus central nervous system based side effects. The potency and selectivity of this compound and of analogues from this class support the potential of H3 receptor antagonists for the treatment of cognitive dysfunction.Keywords
This publication has 42 references indexed in Scilit:
- Genetic and pharmacological aspects of histamine H3 receptor heterogeneityLife Sciences, 2003
- Pharmacological Characterization of the Novel Histamine H3-Receptor Antagonist N-(3,5-Dichlorophenyl)-N′-[[4-(1 H-imidazol-4-ylmethyl)phenyl]-methyl]-urea (SCH 79687)The Journal of Pharmacology and Experimental Therapeutics, 2003
- Recent advances in histamine H3/H4receptor ligandsExpert Opinion on Therapeutic Patents, 2003
- Histamine H3‐receptor‐mediated [35S]GTPγ[S] binding: evidence for constitutive activity of the recombinant and native rat and human H3 receptorsBritish Journal of Pharmacology, 2002
- The physiology of brain histamineProgress in Neurobiology, 2001
- High constitutive activity of native H3 receptors regulates histamine neurons in brainNature, 2000
- Cloning and cerebral expression of the guinea pig histamine H3 receptorNeuroReport, 2000
- Cloning and Functional Expression of the Human Histamine H3ReceptorMolecular Pharmacology, 1999
- Histamine H3 ligands: just pharmacological tools or potential therapeutic agents?Journal of Medicinal Chemistry, 1990
- Three loci related to the src oncogene and tyrosine-specific protein kinase activity in DrosophilaNature, 1983